SHIRE PLC
Holding(s) in Company
July 11, 2016 - Shire plc (LSE: SHP, NASDAQ: SHPG)
1. Identity of the issuer or the underlying issuer Shire plc
of existing shares to which voting rights are
attached: ii
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result
in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to
qualifying financial instruments
An event changing the breakdown of voting rights
Other (please Decrease in voting rights ownership due to company increase in X
specify): shares outstanding
3. Full name of person(s) subject to the Harbor International Fund
notification obligation: iii (a series of Harbor Funds, a Delaware Statutory
Trust)
4. Full name of shareholder(s)
(if different from 3.):iv
5. Date of the transaction and date on Trade Date: June 30, 2016
which the threshold is crossed or Settlement Date: July 5, 2016
reached: v
6. Date on which issuer notified: July 8, 2016
7. Threshold(s) that is/are crossed or 3% of issuer's voting rights
reached: vi, vii
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of Situation previous Resulting situation after the triggering transaction
shares to the triggering
transaction
if possible
using Number Number Number Number of voting % of voting rights x
the ISIN CODE of of of shares rights
Shares Voting
Rights Direct Direct xi Indirect Direct Indirect
xii
Common 19,156,536 19,156,536 19,156,536 19,156,536 N/A 2.13% N/A
SEDOL: B2QKY05
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date xiii Conversion Period xiv rights that may be rights
acquired if the
instrument is
exercised/ converted.
N/A N/A N/A N/A N/A
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial Exercise Expiration Exercise/ Number of voting % of voting rights
instrument price date xvii Conversion rights instrument xix, xx
period xviii refers to
N/A N/A N/A N/A N/A Nominal Delta
N/A N/A
Total (A+B+C)
Number of voting rights Percentage of voting rights
19,156,536 2.13%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
N/A
Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will cease N/A
to hold:
12. Date on which proxy holder will cease to hold N/A
voting rights:
13. Additional information: Completed in Chicago, Illinois, USA
on July 8, 2016
14. Contact name: Jodie L. Crotteau
Assistant Secretary
15. Contact telephone number: 312-443-4428
For further information please contact:
Investor Relations
Sarah Elton-Farr seltonfarr@shire.com +44 1256 894157
NOTES TO EDITORS
Shire is the leading global biotechnology company focused on serving people
with rare diseases and other highly specialized conditions. We strive to
develop best-in-class products, many of which are available in more than 100
countries across core therapeutic areas including Hematology, Immunology,
Neuroscience, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine
/ Endocrine and Hereditary Angioedema; a growing franchise in Oncology; and an
emerging, innovative pipeline in Ophthalmics.
Our employees come to work every day with a shared mission: to develop and
deliver breakthrough therapies for the hundreds of millions of people in the
world affected by rare diseases and other high-need conditions, and who lack
effective therapies to live their lives to the fullest.
www.shire.com
SHIRE PLC : - Holding(s) in Company
July 11, 2016 at 07:01 am EDT
Share
Share
© PRNewswire - 2016
